2024 / 01

Next Paper
DOI: 10.24075/brsmu.2024.006

ORIGINAL RESEARCH

Filaggrin loss-of-function mutations 2282del4, R501X, R2447X and S3247X in atopic dermatitis

Verbenko DA, Karamova AE, Chickin VV, Kozlova IV, Aulova KM, Kubanov AA, Gorodnichev PV
About authors

State Research Center of Dermatovenereology and Cosmetology of the Ministry of Health of the Russian Federation

Correspondence should be addressed: Dmitry Anatolyevich Verbenko
Korolenko, 3/6, office 320, Moscow, 117076, Russia; moc.liamg@oknebrev

About paper

Funding: the research was financially supported by the Ministry of Health of the Russian Federation (State Task for the State Research Center of Dermatovenereology and Cosmetology № 056-00116-21-00-6 for 2021-2023).

Author contribution: AE Karamova, VV Chikin, KM Aulova, PV Gorodnichev — examination of patients, diagnosing, SCORAD calculation, obtaining informed consent, sampling patients' biomaterial; DA Verbenko — research planning, molecular genetic experiments, manuscript authoring; IV Kozlova — analysis of uniqueness of the oligonucleotides hybridizing to the loss-of-function mutations in the FLG gene; AE Karamova — manuscript editing; AA Kubanov — general guidance, manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the State Research Center of Dermatovenereology and Cosmetology (Minutes #1 of January 29, 2021), and meets the standards of good clinical practice and evidence-based medicine. All patients included in the study have read and signed a voluntary informed consent to participate therein.

Received: 2024-01-12 Accepted: 2024-02-10 Published online: 2024-02-25
|
  1. Zaslavskij DV, Svitich OA, Kudrjavceva AV. Atopicheskij dermatit. Mezhdisciplinarnyj podhod k diagnostike i lecheniju: Rukovodstvo dlja vrachej. Moskva: GJeOTAR-Media, 2024; 288 s. Russian.
  2. Klinicheskie rekomendacii. Atopicheskij dermatit. Utverzhdeny Minzdravom RF. Dostupno po ssylke: https://www.nrcii.ru/specialistam/klinrecommend/atopic_dermatitis_2020.pdf. Russian.
  3. Kubanov AA, Bogdanova EV. Resursy i rezul'taty dejatel'nosti medicinskih organizacij, okazyvajushhih medicinskuju pomoshh' po profilju «dermatovenerologija», v Rossijskoj Federacii v 2016–2022 gg. Vestnik dermatologii i venerologii. 2023; 99 (4): 18–40. Dostupno po ssylke: https://doi.org/10.25208/vdv12385. Russian.
  4. Kotova EG, Kobjakova OS, Kubanov AA, Starodubov VI, Aleksandrova GA, Bogdanova EV, i dr. Resursy i dejatel'nost' medicinskih organizacij dermatovenerologicheskogo profilja. Zabolevaemost' infekcijami, peredavaemymi polovym putem, zaraznymi kozhnymi boleznjami i boleznjami kozhi v 2022 godu: statisticheskie materialy. M.: FGBU «CNIIOIZ» Minzdrava Rossii, 2023; 209 s. DOI: 10.21045/978-5-94116-130-0-2023. Russian.
  5. Traidl S, Freimooser S, Werfel T. Janus kinase inhibitors for the therapy of atopic dermatitis. Allergol Select. 2021; 5: 293–304. DOI: 10.5414/ALX02272E.
  6. Gelezhe KA, Kudravtseva AV, Ryzhii E, Khachatryan LG, Bogdanova EA, Svitich OA. The role of the skin microbiome in the development of allergic inflammation in atopic dermatitis. New Armenian Medical Journal. 2021; 15 (1): 100–8.
  7. Gorskij VS, Bljumina VA. Sovremennye predstavlenija o patogeneze atopicheskogo dermatita. Immunopatologija, allergologija, infektologija. 2022; 3: 70–76. DOI: 10.14427/jipai.2022.3.70. Russian.
  8. Beljaeva TM, Ponomarenko IV, Churnosov MI. Molekuljarnogeneticheskie determinanty atopicheskogo dermatita (dannye polnogenomnyh issledovanij). Klinicheskaja dermatologija i venerologija. 2020; 19 (5): 615–21. DOI: 10.17116/klinderma202019051615. Russian.
  9. Svitich OA, Olisova OJu, Meremjanina EA., Rasskazova ND, Fomina VA, Potapova MB. Rol' polimorfnyh markerov v genah TLR2, TLR4 i TLR9 v riske razvitija atopicheskogo dermatita. Medicinskaja immunologija. 2023; 25 (5): 1043–8. DOI: 10.15789/1563-0625-AOS-2807. Russian.
  10. Smolkina OJu, Bystrickaja EP, Svitich OA, Piruzjan AL, Denisova EV, Korsunskaja IM, i dr. Analiz metilirovanija DNK v porazhennoj i neporazhennoj kozhe u vzroslyh pacientov s atopicheskim dermatitom. Molekuljarnaja medicina, 2021; 19 (1): 53–58. DOI: 10.29296/24999490-2021-01-08. Russian.
  11. Gupta J, Margolis DJ. Filaggrin gene mutations with special reference to atopic dermatitis. Curr Treat Options Allergy. 2020; 7 (3): 403–13. DOI: 10.1007/s40521-020-00271-x.
  12. Barker JN, Palmer CN, Zhao Y, Liao H, Hull PR, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to earlyonset atopic dermatitis that persists into adulthood. J Invest Dermatol. 2007; 127 (3): 564–7. DOI: 10.1038/sj.jid.5700587.
  13. Tamrazova OB, Gluhova EA. Unikal'naja molekula filaggrin v strukture jepidermisa i ee rol' v razvitii kseroza i patogeneza atopicheskogo dermatita. Klinicheskaja dermatologija i venerologija. 2021; 20 (6): 102–10. DOI: 10.17116/klinderma202120061102. Russian.
  14. Moosbrugger-Martinz V, Leprince C, Méchin M-C, Simon M, Blunder S, Gruber R, et al. Revisiting the roles of filaggrin in atopic dermatitis. Int J Mol Sci. 2022; 23: 5318. DOI: 10.3390/ijms23105318/.
  15. Chiricozzi A, Maurelli M, Calabrese L, Peris K, Girolomoni G. Overview of atopic dermatitis in different ethnic groups. J Clin Med. 2023; 12: 2701. DOI: 10.3390/jcm12072701.
  16. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011; 365 (14): 1315–27. DOI: 10.1056/NEJMra1011040.
  17. X.F. Colin C. Wong, Simon L.I.J. Denil, Jia Nee Foo, Huijia Chen, Angeline Su Ling Tay, Rebecca L. Haines, et al. Array-based sequencing of filaggrin gene for comprehensive detection of diseaseassociated variants. Journal of Allergy and Clinical Immunology. 2018; 141 (2): 814–6. DOI: 10.1016/j.jaci.2017.10.001.
  18. Thyssen JP, Bikle DD, Elias PM. Evidence that loss-of-function filaggrin gene mutations evolved in northern europeans to favor intracutaneous vitamin D3 production. Evol Biol. 2014; 41 (3): 388–96. DOI: 10.1007/s11692-014-9282-7.
  19. Rodríguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown SJ, Cordell HJ, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol. 2009; 123 (6): 1361–70. DOI: 10.1016/j.jaci.2009.03.036.
  20. Makarova SI, Mitrofanov DV, Komova EG, Kaloshkin IV, Shintjapina AB, Kaznacheeva LF, i dr. Rol' mutacij gena filaggrina, vedushhih k snizheniju kolichestva belka, v razvitii atopicheskogo dermatita i bronhial'noj astmy u detej. Sibirskij nauchnyj medicinskij zhurnal. 2021; 41 (3): 58–63. DOI: 10.18699/SSMJ20210308. Russian.
  21. Varlamov EE, Pampura AN. Pervichnaja profilaktika atopicheskogo dermatita u detej. Rossijskij vestnik perinatologii i pediatrii. 2015; 60 (5): 21—25. Russian.
  22. Gruber R, Janecke A, Fauth C, et al. Filaggrin mutations p.R501X and c.2282del4 in ichthyosis vulgaris. Eur J Hum Genet. 2007; 15, 179–84. DOI: 10.1038/sj.ejhg.5201742.
  23. Eremina AA, Gerlinger AV, Makeenko OA, Koh NV, Sergeeva IG. Vnedrenie sovremennyh geneticheskih i instrumental'nyh metodov obsledovanija v vedenii pacientov s vul'garnym ihtiozom i atopicheskim dermatitom. Klinicheskaja dermatologija i venerologija. 2023; 22 (4): 399–405. DOI: 10.17116/klinderma202322041399. Russian.
  24. Makeenko OA, Koh NV, Sergeeva IG. Klinicheskij razbor pacientov gomozigot po mutacii 2282del4 (rs558269137) v gene filaggrina. Klinicheskaja dermatologija i venerologija. 2022; 21 (3): 390–98. Dostupno po ssylke: https://doi.org/10.17116/klinderma202221031390. Russian.
  25. Chikin VV, Karamova AJe, Kubanov AA, Zhilova MB, Gorodnichev PV, Aulova KM. Uzkopolosnaja srednevolnovaja ul'trafioletovaja terapija bol'nyh atopicheskim dermatitom: analiz faktorov, vlijajushhih na vyrazhennost' terapevticheskogo jeffekta. Vestnik dermatologii i venerologii. 2023; 99 (5): 52–63. DOI: 10.25208/ vdv15828. Russian.
  26. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta DermVenereol. 1980; 92 (Suppl): 44–47.
  27. Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, et al. European Task Force on Atopic Dermatitis/ EADV Eczema Task Force. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020; 34 (12): 2717–44. DOI: 10.1111/jdv.16892.
  28. Standard Nucleotide BLAST. National Center for Biotechnology Information. U.S National Library of Medicine. Available from: https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch.
  29. Maksimova JuV, Svechnikova EV, Maksimov VN, Lykva SG. Mutacii v gene filaggrina i atopicheskij dermatit. Klinicheskaja dermatologija i venerologija. 2014; 3: 58–62. Russian.
  30. Dvornyk V, Ponomarenko I, Belyaeva T, Reshetnikov E, Churnosov M. Filaggrin gene polymorphisms are associated with atopic dermatitis in women but not in men in the Caucasian population of Central Russia. PLoS ONE. 2021; 16 (12): e0261026. DOI: 10.1371/journal.pone.0261026.
  31. Gimalova GF, Karunas AS, Fedorova YY, Khusnutdinova EK. The study of filaggrin gene mutations and copy number variation in atopic dermatitis patients from Volga-Ural region of Russia. Gene. 2016; 591: 85–89. DOI: 10.1016/j.gene.2016.06.054.
  32. Greisenegger E, Novak N, Maintz L, Bieber T, Zimprich F, Haubenberger D, et al. Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2010; 24: 607–10. DOI: 10.1111/j.1468-3083.2009.03469.x.
  33. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol. 2006; 118 (1): 214–9. DOI: 10.1016/j.jaci.2006.05.004. Erratum in: J Allergy Clin Immunol. 2006; 118 (4): 922. Erratum in: J Allergy Clin Immunol. 2006; 118 (3): 724.
  34. Giardina E, Paolillo N, Sinibaldi C, Novelli G. R501X and 2282del4 filaggrin mutations do not confer susceptibility to psoriasis and atopic dermatitis in Italian patients. Dermatology. 2008; 216 (1): 83–4. DOI: 10.1159/000109365.
  35. Luukkonen TM, Kiiski V, Ahola M, Mandelin J, Virtanen H, Pöyhönen M, et al. The value of FLG null mutations in predicting treatment response in atopic dermatitis: an observational study in finnish patients. Acta Derm Venereol. 2017; 97 (4): 456–63. DOI: 10.2340/00015555-2578.
  36. dbSNP Short Genetic Variations. Availabale from: https://www. ncbi.nlm.nih.gov/snp/rs558269137#frequency_tab (accessed 18 Dec 2023).
  37. Smieszek SP, Welsh S, Xiao C, et al. Correlation of age-of-onset of atopic dermatitis with filaggrin loss-of-function variant status. Sci Rep. 2020; 10: 2721. DOI: 10.1038/s41598-020-59627-7.
  38. Schuler CF, Allison C. Billi, Emanual Maverakis, Lam C. Tsoi, Johann E. Gudjonsson, Novel insights into atopic dermatitis. Journal of Allergy and Clinical Immunology. 2023; 151 (5): 1145–54. DOI: 10.1016/j.jaci.2022.10.023.
  39. Bakker DS, de Graaf M, Nierkens S, Delemarre EM, Knol E, van Wijk F, et al. Unraveling heterogeneity in pediatric atopic dermatitis: identification of serum biomarker based patient clusters. J Allergy Clin Immunol. 2022; 149: 125–34. DOI: 10.1016/j.jaci.2021.06.029.
  40. Tokura Y, Hayano S. Subtypes of atopic dermatitis: From phenotype to endotype. Allergology International. 2022; 71 (1): 14–24. DOI: 10.1016/j.alit.2021.07.003.